<SEC-DOCUMENT>0001079973-25-001444.txt : 20250910
<SEC-HEADER>0001079973-25-001444.hdr.sgml : 20250910
<ACCEPTANCE-DATETIME>20250910163827
ACCESSION NUMBER:		0001079973-25-001444
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250910
DATE AS OF CHANGE:		20250910

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lite Strategy, Inc.
		CENTRAL INDEX KEY:			0001262104
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				510407811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-79594
		FILM NUMBER:		251306308

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-369-7100

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD
		STREET 2:		SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEI Pharma, Inc.
		DATE OF NAME CHANGE:	20120629

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARSHALL EDWARDS INC
		DATE OF NAME CHANGE:	20030902

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Schornstein Alexander
		CENTRAL INDEX KEY:			0001999256
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	MAIL ADDRESS:	
		STREET 1:		KAISER-FRIEDRICH-ALLEE 2
		CITY:			AACHEN
		STATE:			2M
		ZIP:			52074
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001079973-25-001248</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Schornstein Alexander -->
          <cik>0001999256</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/09/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001262104</issuerCik>
        <issuerName>MEI Pharma, Inc.</issuerName>
        <issuerCusip>55279B301</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>9920 Pacific Heights Blvd</com:street1>
          <com:street2>Suite 150</com:street2>
          <com:city>San Diego</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Alexander Schornstein</reportingPersonName>
      <citizenshipOrOrganization>2M</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4365472.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4365472.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4365472.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>13.29</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>MEI Pharma, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>9920 Pacific Heights Blvd., Suite 150 San Diego, CA, 92121</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Alexander Schornstein</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Kaiser-Friedrich-Allee 2, 52074 Aachen
Germany
004915142314669</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Germany</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>4,365,472

Includes 4,140,472 shares of Common Stock held by Alexander Schornstein and 225,000 shares of Common Stock held by Camino Capital GmbH, in which Alexander Schornstein is the sole beneficial owner and has sole voting power.

As disclosed in the Company's report on Form 8-K filed with the United States Securities and Exchange Commission on September 10, 2025, the Company, pursuant to an amendment to its amended and restated certificate of incorporation filed with the Secretary of State of the State of Delaware, has changed his name to Lite Strategy, Inc. effective September 10, 2025 and will being trading under its new name and symbol "LITS" on September 11, 2025.

On the period from August 11, 2025 to September 9, 2025, the Reporting Person made several purchases of the Issuer's shares, causing ownership to exceed ten percent on September 9, 2025. Consideration for the shares was obtained from the personal funds of the Reporting Person. The Reporting Person did not acquire the securities with any purpose, or with the effect, of changing or influencing the control of the issuer, or in connection with or as a participant in any transaction having that purpose or effect, and is thus eligible to file a short-form statement on Schedule 13G pursuant to ss. 240.13d-1(c) of the Securities Exchange Act of 1934.</amountBeneficiallyOwned>
        <classPercent>13.29%

Based upon 32,837,743 shares of common stock currently issued and outstanding, as stated in the Company's registration statement on Form S-3 Amendment No. 1 filed with the United State Securities and Exchange Commission on August 26, 2025, prior to the completion of the offering contemplated by the registration statement.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>4,365,472</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>4,365,472</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Alexander Schornstein</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Alexander Schornstein</signature>
        <title>Alexander Schornstein</title>
        <date>09/10/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
